Epilepsy Therapies & Diagnostics Development XVIII Symposium (ETDD)
Home » News / Events / ETDD 2025 XVIII
Don’t miss this opportunity to meet Corinne Roucard, PhD, SynapCell President & Executive Chairwoman who will be delivering a talk sharing insights on the different preclinical models of epilepsies and how to assess ASMs efficacy using quantitative electroencephalography (qEEG).
SynapCell’s expertise spans from focal epilepsy to generalized epilepsy, including focal to secondary generalized epilepsy.
Wednesday, May 28th, 11:40-11:50 SESSION III: PRECLINICAL- PIPELINE
Preclinical Models of Epilepsies and Beyond – Corinne Roucard, PhD, Synapcell
As sponsors, we’re especially excited to support this important event and contribute to the conversations shaping the future of Drug Discovery.
Are you attending? Come meet us, we’d love to connect or feel free to message us to schedule a meeting!